Z Pharmaceutical Global Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 1 Year 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.50 M
as on 04-12-2024
About Z Pharmaceutical Global
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vikash Srivastava and Amit Shrivastava serve as directors at the Company.
- CIN/LLPIN
U85100OR2023PTC041831
- Company No.
041831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2023
- Date of AGM
28 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Z Pharmaceutical Global?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Srivastava  | Managing Director | 19-Jan-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Shrivastava | Director | 19-Jan-2023 | Current |
Financial Performance of Z Pharmaceutical Global.
Enhance accessibility to Z Pharmaceutical Global's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Z Pharmaceutical Global?
Unlock access to Z Pharmaceutical Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Diaitasure Global Private LimitedActive 5 years 9 monthsVikash Srivastava and Amit Shrivastava are mutual person
- G. D. Financial Solutions Private LimitedActive 15 years 6 months
Amit Shrivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 09 Aug 2023 | ₹3.50 M | Satisfied |
How Many Employees Work at Z Pharmaceutical Global?
Z Pharmaceutical Global has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Z Pharmaceutical Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Z Pharmaceutical Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
